SNX0723 is an orally bioavailable, Hsp90 inhibitor that exhibits antitumour activity in vitro. It has an EC50 for inhibition of α-synuclein (αSyn) oligomerization of approximately 48 nM and was able to rescue αSyn-induced toxicity. References:

纯度：≥98%

CAS：1073969-18-2